Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

What to expect from the Q1 earnings reporting cycle: https://www.marketbeat.com/logos/articles/med_20231227123634_chart-spy-12272023ver001.png
What to expect from the Q1 earnings reporting cycle

The New Year is almost upon us and, with it, the next earnings reporting cycle. The calendar Q1/fiscal Q4 cycle is expected to bring another quarter of growth for the S&P 500 (NYSEARCA: SPY) and

If Ray Dalio took profits here, then this stock needs to catch up: https://www.marketbeat.com/logos/articles/med_20231227200044_if-ray-dalio-took-profits-here-then-this-stock-nee.jpg
If Ray Dalio took profits here, then this stock needs to catch up

If there is one thing that investors need help getting used to, it is learning where - and where not - to take cues for potentially better places to invest when they come up. Many "experts" are

3 tech stocks on the verge of major breakouts: https://www.marketbeat.com/logos/articles/med_20231227192924_3-tech-stocks-on-the-verge-of-major-breakouts.jpg
3 tech stocks on the verge of major breakouts

As we near the year's end, the technology sector is concluding on an impressive note, having recently reached new all-time highs. The tech sector has taken the lead throughout the year, outpacing

Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.: https://www.irw-press.at/prcom/images/messages/2023/73122/AC12-28-23AC1.001.png
Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.

Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. 359% Biotech Aktientip nach 134.452% mit Biogen

 

28.12.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Are high-yield Dow Dogs a good buy for 2024?: https://www.marketbeat.com/logos/articles/med_20231227102631_chart-vz-12272023-002ver001.png
Are high-yield Dow Dogs a good buy for 2024?

The Dogs of the Dow theory assumes that this year’s worst performers will be the best-performing stocks in the next. If not, they should provide solid rebounds due to their “lower” value, and many

Synopsys offers to acquire Ansys, sparks stock surge: https://www.marketbeat.com/logos/articles/med_20231227101520_synopsys-offers-to-acquire-ansys-sparks-stock-surg.jpg
Synopsys offers to acquire Ansys, sparks stock surge

Shareholders of engineering simulation software maker Ansys Inc. (NASDAQ: ANSS) got a holiday gift as the stock rallied more than 18% on December 22 on news that Synopsys Inc. (NASDAQ: SNPS) was

Buffett keeps buying Occidental Petroleum, should you?: https://www.marketbeat.com/logos/articles/med_20231227091215_chart-oxy-12272023ver001.png
Buffett keeps buying Occidental Petroleum, should you?

The price action in Occidental Petroleum (NYSE: OXY) has been range-bound for the last two years and may not break out of the range soon. However, the stock retreated to the low end of the range

The most upgraded stocks from 2023: buy, sell or hold?: https://www.marketbeat.com/logos/articles/med_20231227081454_chart-crm-12272023ver001.png
The most upgraded stocks from 2023: buy, sell or hold?

2023 was a busy year for the analysts; their activity has helped to lift the S&P 500 (NYSEARCA: SPY) 25% for the year and may help drive it to new highs in 2025. The most upgraded stocks for the

Liquidia: Court victory the awakening of an industry giant?: https://www.marketbeat.com/logos/articles/med_20231227075636_liquidia-court-victory-the-awakening-of-an-industr.jpg
Liquidia: Court victory the awakening of an industry giant?

Shares of Liquidia (NASDAQ: LQDA) have been one of the top-performing stocks over the final quarter, with shares up almost 90% over the previous three months. However, the vast majority of those

T-Mobile is suddenly the industry gem with analyst target boosts: https://www.marketbeat.com/logos/articles/med_20231227075346_t-mobile-is-suddenly-the-industry-gem-with-analyst.jpg
T-Mobile is suddenly the industry gem with analyst target boosts

There are always stocks that feel very cold to the touch, especially shivering to those who cannot afford to buy thousands of shares to make every uptick count. Companies in the technology sector

Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen  nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/73117/AC12-27-23_ac1.001.png
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Neuer 359% Biotech Aktientip nach 15973% mit BioNTech ($BNTX)

 

27.12.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Align Technology: Protected by more factors than any other stock: https://www.marketbeat.com/logos/articles/med_20231226071503_align-technology-protected-by-more-factors-than-an.jpg
Align Technology: Protected by more factors than any other stock

Because the past few months in the stock market have been a wild emotional roller coaster, most investors are now looking for the most logical and fundamental reasons to justify investing in any

XLF's stellar year-end run: key insights & top performers: https://www.marketbeat.com/logos/articles/med_20231226070512_xlfs-stellar-year-end-run-key-insights-top-perform.jpg
XLF's stellar year-end run: key insights & top performers

The financial sector and popular sector ETF Financial Select Sector Fund (NYSE: XLF) has enjoyed a stellar end to the year. A quick glance at the XLF’s daily chart almost makes it appear like the

Intel ups the ante in the AI chip arena against Nvidia: https://www.marketbeat.com/logos/articles/med_20231224105734_chart-intc2.jpg
Intel ups the ante in the AI chip arena against Nvidia

While the artificial intelligence (AI) computing market has been dominated by Nvidia Co. (NASDAQ: NVDA), new challengers are invading their turf with their own AI accelerators. 2024 should prove

Zillow is the stock to show you the new homes Buffett just bet on: https://www.marketbeat.com/logos/articles/med_20231225182640_zillow-is-the-stock-to-show-you-the-new-homes-buff.jpg
Zillow is the stock to show you the new homes Buffett just bet on

Industries that have stood the test of time are typically very reliable and provide an extended track record of success; what most people (and investors) need to prepare for is an inevitable wave

Will these 3 heavily shorted stocks keep squeezing?: https://www.marketbeat.com/logos/articles/med_20231225183111_will-these-3-heavily-shorted-stocks-keep-squeezing.jpg
Will these 3 heavily shorted stocks keep squeezing?

As the overall market edges closer to its all-time high, with the SPDR S&P 500 ETF Trust (NYSE: SPY) trading at its 52-week high, highly shorted, previously beaten-down stocks have been a

It's here: Netflix's rally is now set by analysts and Ray Dalio: https://www.marketbeat.com/logos/articles/med_20231225182858_its-here-netflixs-rally-is-now-set-by-analysts-and.jpg
It's here: Netflix's rally is now set by analysts and Ray Dalio

Most investors can only dream of matching even 1.0% of a successful investment track record like Ray Dalio's. His hedge fund, Bridgewater Associates, is the largest one in the world, and they have

What is the 'Magnificent Seven', and how to gain exposure?: https://www.marketbeat.com/logos/articles/med_20231222071709_what-is-the-magnificent-seven-and-how-to-gain-expo.jpg
What is the 'Magnificent Seven', and how to gain exposure?

Move over FAANG, there’s a new and improved basket of stocks leading the way: The ‘Magnificent Seven.’

Earlier this year, Bank of America's Michael Hartnett dubbed a group of top stocks the

Get ready to ring in the New Year with these upgrades: https://www.marketbeat.com/logos/articles/med_20231221111711_chart-wday-12212023ver001.png
Get ready to ring in the New Year with these upgrades

Santa Claus rally or not, the analysts are upping their targets on some high-quality tech names that stand to rally strongly in 2024. 

Salesforce.com Inc. (NYSE: CRM)Zscaler Inc. (NASDAQ: ZS) a

Nike’s miss could be our opportunity: https://www.marketbeat.com/logos/articles/med_20231222071331_nikes-miss-could-be-our-opportunity.jpg
Nike’s miss could be our opportunity

The big swoosh is set to look a little deflated heading into 2024 after Nike Inc (NYSE: NKE) reported its fiscal Q2 earnings last night. Shares had been rallying since the end of September

Tesla's bold rally: Promising pattern as it overcomes roadblocks: https://www.marketbeat.com/logos/articles/med_20231222071007_teslas-bold-rally-promising-pattern-as-it-overcome.jpg
Tesla's bold rally: Promising pattern as it overcomes roadblocks

It’s tough to think of a company whose CEO is more polarizing than Tesla Inc.’s (NASDAQ: TSLA) Elon Musk. 

But doubts about Musk, along with an embarrassing incident in which a new Tesla

De.mem erwartet 2023 einen neuen Einnahmenrekord: https://www.irw-press.at/prcom/images/messages/2023/73112/KW51_De.mem2212.001.jpeg
De.mem erwartet 2023 einen neuen Einnahmenrekord

Der börsennotierte Spezialist für dezentrale membranbasierte Wasseraufbereitungsanlagen und Dienstleistungen ist in den vergangenen Jahren stark gewachsen. Für die Zukunft sieht sich das

RV stocks: A comfortable way to ride falling interest rates: https://www.marketbeat.com/logos/articles/med_20231220101851_rv-stocks-are-a-comfortable-way-to-ride-falling-in.jpg
RV stocks: A comfortable way to ride falling interest rates

RV stocks have been struggling to regain traction following the social-distancing craze that drove them to record highs. The problems were rising prices and an inventory glut compounded by high

Why Micron’s 2024 could be its best year ever: https://www.marketbeat.com/logos/articles/med_20231221075125_why-microns-2024-could-be-its-best-year-ever.jpg
Why Micron’s 2024 could be its best year ever

With just a few days left until Santa comes, shares of Micron Technology Inc (NASDAQ: MU) are set to give investors an early Christmas present. They jumped 5% in last night’s after-hours sessions

Pfizer's chaotic year wraps up with plunging stock, grim guidance: https://www.marketbeat.com/logos/articles/med_20231220201736_pfizers-chaotic-year-wraps-up-with-plunging-stock.jpg
Pfizer's chaotic year wraps up with plunging stock, grim guidance

Investors who own Pfizer Inc. (NYSE: PFE) may have expected 2023 to be what football teams call a "rebuilding year." The company shifted its focus away from COVID-19 drugs and toward potential